Financials

  • Market Capitalization 186.49 M
  • Employee 187
  • Founded 2012
  • CEO Daniel A. de Boer
  • Website www.proqr.com
  • Headquarter Netherlands
  • FIGI UNKNOWN
  • Industry Biotechnology

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3679
TNXP
Tonix Pharmaceuticals Holding Corp. - Common Stock
11.46 USD+3.62%-8.47%-0.52%-23.65%182.68 M USD
3681
TNYA
Tenaya Therapeutics, Inc. - Common Stock
0.84 USD-2.33%-4.55%+16.67%+21.74%182.28 M USD
3686
ACOG
Alpha Cognition Inc. - Common Stock
8.35 USD+3.73%+2.08%+38.02%-18.93%181.81 M USD
3688
ARCT
Arcturus Therapeutics Holdings Inc. - Common Stock
6.38 USD+0.16%-12.60%-12.24%-51.92%181.34 M USD

Frequently asked questions about ProQR Therapeutics N.V. - Ordinary Shares

What is the ProQR Therapeutics N.V. - Ordinary Shares stock price today?

The current price of ProQR Therapeutics N.V. - Ordinary Shares (PRQR) is 1.77. Over the past 24 hours, the stock has changed by +4.12%. Follow the PRQR chart for real-time price dynamics.

What is the stock ticker of ProQR Therapeutics N.V. - Ordinary Shares?

ProQR Therapeutics N.V. - Ordinary Shares trades under the ticker PRQR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is ProQR Therapeutics N.V. - Ordinary Shares stock going up?

PRQR has changed by +5.36% over the last week, +12.74% over the last month, and -24.68% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does ProQR Therapeutics N.V. - Ordinary Shares have?

As of the latest available data, ProQR Therapeutics N.V. - Ordinary Shares has 187 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy ProQR Therapeutics N.V. - Ordinary Shares stock?

You can buy ProQR Therapeutics N.V. - Ordinary Shares (PRQR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in ProQR Therapeutics N.V. - Ordinary Shares stock?

Investing in ProQR Therapeutics N.V. - Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PRQR chart and related analysis on metatrader.com as part of your research.

ProQR Therapeutics N.V. - Ordinary Shares

ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer.

News